NASSCOM GCC Summit 2025

What’s Next for Global Capability Centers (GCCs)? Cactus Life Sciences at the NASSCOM GCC Summit 2025

The theme for this year’s NASSCOM GCC Summit, “The Next GCC Frontier: Ambition, Agility, Ascent,” couldn’t have been more apt. Held in Hyderabad on April 22–23, 2025, the event brought together visionary leaders, strategists, technologists, and innovators to examine the evolving role of India’s global capability centers (GCCs) and their journey from execution engines to…...
Read More

Top Stories

“Voice of Patient” in Publications: Trends and

This page contains a poster presented at the 21st Annual...
MAPS 2025

MAPS 2025 Decoded: The Medical Affairs Playbook

At the MAPS Americas 2025 conference in New Orleans, one of...
DIA MASC 2025

Medical Affairs 2.0: GenAI as the Catalyst for

Digital and AI were hot topics underpinning many of the...
Empowering Medical Affairs by Leveraging Modular Content

Key Solution Guide: Empowering Medical Affairs by Leveraging Modular Content

In the biopharma sector, the overwhelming influx of medical data necessitates an efficient content strategy...
AI, ML, NLP, AR/VR, Blockchain in Healthcare

Emerging Technologies: Healthcare Communication Friend or Foe?

Embracing emerging technologies and innovations is not just an option but a necessity for biopharma...
Artificial Intelligence and Writing

Breaking Barriers: Exploring the Power of AI and NLP in Scientific Communication

Learn how medical publication professionals and medical affairs teams can embrace AI and NLP tools...

Launch Excellence: The Path Forward for Medical Affairs

Learn how Medical Affairs can redefine launch excellence by streamlining the journey from clinical trial...
Clinical Trial Pain Points

Pharma, Physician, and Patient Pain Points Regarding Clinical Trials

Pharma, physicians, and patients consistently face challenges related to clinical trials. Here's a quick look...
FINAL Clinical Trial Summaries Blog-Banner-810x540

Clinical Trial Summaries – What Are They and Why Do They Matter for Pharma?

A majority of patients feel lay summaries for clinical trials are very important and won’t...

Learn more ABOUT our company.